Fingerprint
Dive into the research topics of 'Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
Henrik Hasle, Jonas Abrahamsson, Erik Forestier, Shau-Yin Ha, Jesper Heldrup, Kirsi Jahnukainen, Olafur Gisli Jonsson, Birgitte Lausen, Josefine Palle, Bernward Zeller
Research output: Contribution to journal › Article › peer-review